This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Photocure Asa. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: **Innovator Tore Gjørsvik: Pioneering Photodynamic Treatment Technologies**
Introduction
Tore Gjørsvik is a prominent inventor based in Gjerdrum, Norway, recognized for his contributions to the field of pharmaceuticals and medical devices. With two patents to his name, he is making significant advancements in photodynamic therapy, particularly in the treatment of bladder cancer. Gjørsvik's innovative approaches focus on enhancing the effectiveness of treatments through improved methodologies.
Latest Patents
Gjørsvik's most recent patents include a groundbreaking method for preparing a liquid pharmaceutical composition. This invention pertains to a dissolution chamber designed to work with a catheter, facilitating the creation of an aqueous solution of a water-soluble photosensitizing agent. This formulation is intended for installation into the bladder for applications in photodynamic diagnosis (PDD) and photodynamic therapy (PDT) for bladder cancer. Moreover, he has developed a device specifically for photodynamic treatment, which aims to effectively address abnormalities, disorders, or diseases affecting the internal surfaces of body cavities or hollow organs.
Career Highlights
Tore Gjørsvik is currently employed at Photocure ASA, a company dedicated to pioneering photodynamic therapy advancements. His work at Photocure has allowed him to collaborate on various projects that strive to improve cancer treatment methodologies, particularly focusing on bladder health. His expertise in pharmaceutical compositions and device engineering has positioned him as a leading figure in his field.
Collaborations
Throughout his career, Gjørsvik has collaborated with several esteemed colleagues, including Aslak Godal and Roger William Rolfe Warren. These partnerships have been essential in fostering innovation and accelerating the development of viable solutions for photodynamic treatments, bringing together a wealth of knowledge and experience.
Conclusion
Tore Gjørsvik's innovative spirit and dedication to improving cancer treatments through photodynamic therapy represent a significant advancement in medical science. His patents are a testament to his commitment to enhancing the quality of life for patients facing bladder cancer. As he continues to advance in his career at Photocure ASA, the medical community eagerly anticipates the impact of his future contributions to the field.